Answers are grounded in this paper and cite their sources.
Endogenous signaling lipids and synthetic T-channel inhibitors share a common molecular mechanism for inhibiting Cav3.3 currents.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: